摘要
目的研究卵巢癌患者血清与腹水透明质酸(hyaluronicacid,HA)含量变化及临床意义。方法采用放射免疫法测定38例卵巢癌患者及42例对照组血清术前及术后HA含量,并测定其中22例恶性肿瘤腹水HA含量。结果恶性卵巢癌组术前血清HA含量显著高于对照组及良性肿瘤组,P=0.003,术后明显下降,手术前后血清HA含量差异有统计学意义,P=0.004;卵巢癌患者低度分化组血清HA含量显著高于中度及高度分化组,P=0.006,腹水HA含量显著高于血清,P=0.008,两者之间呈显著正相关,r=0.82,P=0.030,淋巴结转移组血清HA含量显著高于无淋巴结转移组,P=0.002。结论HA与肿瘤的生物学特性密切相关,其血清及腹水含量对于病情判断及监测具有重要的临床意义。
OBJECTIVE: To investigate the hyaluronic acid (HA) level of serum and ascites in ovarian carcinoma. METHODS: Serum and ascites samples from 38 patients with ovarian carcinoma and 42 control cases were collected ant their HA levels were assayed by radioimmunoassay. RESULTS: HA level of serum in patients with ovarian carcinoma was significantly higher than that in control group and in patients with benign tumors (P = 0. 003) before operation. The HA level before yerafion was significantly higher than that affter operation (P=0. 004). The serum level of HA in low-differentiated tumors was higher than that in the moderate-differentiated tumors and high-differentiated tumors (P=0. 006). The HA level of ascites was higher than that of serum (P=0. 008) in malignant tumors and they were significantly correlated with each other (r = 0.82, P = 0. 030). The serum level of HA in the patients with lymph node metastasis was higher than that without lymph node metastasis (P = 0. 002). CONCLUSIONS.. HA in serum and ascites expressed higher in ovarian carcinoma than benign group. This investigation reveales that HA is an important diameter reflecting tumor biological characteristics,
出处
《中华肿瘤防治杂志》
CAS
2006年第22期1728-1729,共2页
Chinese Journal of Cancer Prevention and Treatment